Fullido, Fairi Shyn .
HRN: 20-36-46 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/16/2023
06/23/2023
IV
995mg
Q6
PCAP D
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes